Bortecad Injection - Bortezomib 2mg Iv Use, Enhanced Shelf Life, Safe Packaging, Quick Results, Highly Effective For Clinical And Personal Use

As Directed by Physician

Dosage Guidelines Administration: Subcutaneous injection (not IV or IM). Starting dose (adults): -thalassemia: 1 mg/kg once every 3 weeks. Myelodysplastic syndromes (MDS): 1 mg/kg once every 3 weeks. Adjustment: If response is inadequate, dose may be increased to 1.25 mg/kg (maximum). Dose interruptions or reductions may be required for side effects (e.g., high hemoglobin, hypertension, bone pain). Treatment goal: Reduce or eliminate the need for red blood cell transfusions. Reconstitution: Each vial must be reconstituted with sterile water before injection

Cool & Dry Place

Store in Cool

1-10 Days

5 Days

1 Week

2mg / vial / box

Packaging DetailsForm: Lyophilized powder for solution (white to off-white).Strengths available:25 mg/vial75 mg/vialContainer: Type I clear glass vial with a rubber stopper and flip-off aluminum seal.Presentation: Each carton contains 1 single-dose vial.Labeling: Vial label and outer carton show drug name (Reblozyl / Luspatercept-aamt), strength, batch/lot number, expiry date, and storage conditions.Reconstitution: Supplied without diluent; requires Sterile Water for Injection (provided separately by healthcare facility).Storage: Refrigerated at 2 C to 8 C, protected from light.

as per industrial standards

124225 INR (Approx.)

230 INR (Approx.)

100 Per Day

2500 Per Week